ACSL3 and triple-negative breast carcinoma: On the other hand, in triple-negative breast cancer, ACSL3 is significantly reduced, resulting in high FAO/low lipid droplet abundance, and serves as a poor prognosis marker of the triple-negative breast cancer metastatic potential.